Point72 Asia (Singapore) Pte. Ltd. Avita Medical, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Avita Medical, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 7 shares of RCEL stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$44% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCEL
# of Institutions
78Shares Held
6.99MCall Options Held
36.4KPut Options Held
26K-
Black Rock Inc. New York, NY1.78MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$9.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA620KShares$3.94 Million0.0% of portfolio
-
State Street Corp Boston, MA527KShares$3.35 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA440KShares$2.79 Million0.98% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $159M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...